CAROLINA
GARCÍA BARROSO
Karolinska Institute
Estocolmo, SueciaPublicaciones en colaboración con investigadores/as de Karolinska Institute (1)
2015
-
Decreased levels of guanosine 3', 5'-monophosphate (cGMP) in cerebrospinal fluid (CSF) are associated with cognitive decline and amyloid pathology in Alzheimer's disease
Neuropathology and Applied Neurobiology, Vol. 41, Núm. 4, pp. 471-482